View in a different locale / language
Methylation of DNA at C5 position of cytosine impacts various cellular processes involving gene expression and chromatin remodelling. These plays a vital role in processes associated with health and development through methylation of promoter regions, cell differentiation, remodelling of chromatin, transposon silencing, etc. Eurofins Genomics offers comprehensive whole genome bisulfite analysis which is an effective method to analyse methylation of whole genomes. Eurofins Genomics has built up a proprietary pipeline to provide cost-efficient methods to customers.
Reduced representation bisulfite sequencing (RRBS) is an efficient method which enables analysis of DNA methylation on genome-scale at single-nucleotide level. Focusing on the genome containing CpG dinucleotides reduces DNA sequencing cost than whole genome. RRBS sequencing combined with bioinformatics analysis provides high resolution DNA methylation detection.
ExomeSeq analysis at Eurofins Genomics represents the pinnacle of medical exome sequencing, offering unparalleled coverage and depth for gene analysis. Our ExomeSeq service delivers more than 97% coverage of 22,000 genes, with a mean read depth of 100X, ensuring that nearly all disease-associated genes are thoroughly examined. With up to 100% coverage (depth coverage ≥20X) of all exons, our ExomeSeq service doubles the gene coverage offered by many competitors, making it the most comprehensive exome sequencing solution available.
The human exome, encompassing the entire coding (exonic) region of the genome, comprises only 1-2% of the genome but contains approximately 85% of all known disease-causing variants. While traditional exome kits cover around 92% of the exome, our ExomeSeq service goes further, enabling clinicians and researchers to uncover previously unrecognised genetic causes of disease with greater precision.
Our ExomeSeq analysis can be performed for individuals (proband), trios (patient and parents), and larger family groups. This flexible approach enables targeted investigation of disease-associated genes linked to a patient's phenotype, supporting accurate diagnosis and research.
GBS is a method for high throughput single nucleotide polymorphism (SNP) discovery and also genotyping in large volume of DNA samples. This method is basically a restriction enzyme-mediated complexity reduction followed by sequencing using Illumina platforms to discover random markers across an entire genome.
Eurofins Genomics offers comprehensive sequencing on Illumina platform. We offer customised experimental design of GBS for association and genotyping studies etc. We have developed standard pipeline for advanced bioinformatics analysis of sequencing data and we provide support of experienced scientist for end-to-end analysis.
At Eurofins Genomics, we offer specialised and customisable database development services tailored to manage and organise genomic and clinical datasets.
Our expertise spans various applications, including whole genome sequencing, transcriptomics, small RNA analysis, exome sequencing, and more. Whether you’re handling a large dataset or planning to generate one, our databases ensure your research data is stored in an organised, accessible, and secure manner.
Ready to share your valuable research data with the global scientific community? Eurofins Genomics offers streamlined, reliable National Centre for Biotechnology Information (NCBI) data submission services, ensuring your data becomes part of the NCBI database, a crucial step for publication and accessibility within the scientific community. From sequencing data to whole-genome projects, we support your research through every step of the submission process.